RISOLID

Main information

  • Trade name:
  • RISOLID 10 mg film-coated tablet
  • Dosage:
  • 10 mg
  • Pharmaceutical form:
  • film-coated tablet
  • Prescription type:
  • Prescription only
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • RISOLID 10 mg film-coated tablet
    Finland
  • Language:
  • English

Therapeutic information

  • Therapeutic area:
  • Chlordiazepoxide
  • Product summary:
  • Suitability for use in older adult patients Chlordiazepoxidum Avoid using in elderly persons. Sedative. A long-acting. Significant adverse effects include drug addiction, cognitive disporder and risk for falls and traffic accidents. Paradoxically, may increase anxiety, restlessness and aggression.

Status

  • Source:
  • Fimea
  • Authorization status:
  • Marketing authorization granted
  • Authorization number:
  • 5314
  • Authorization date:
  • 27-01-2009
  • Last update:
  • 21-02-2018